I'm somewhat familiar with Shivom and there are important differences in our projects. I've gone to great lengths to explain these details on the site - if your'e curious, I'd encourage you to at least watch the about us video.
The soft cap is 7.5 million tokens @ aprox $0.40 per token. The Contract will refund ETH should we fail to raise the soft-cap.
The hard cap will be set by the market & time-frame of the sale.
However, the forming EOS community of "token redeemers" will control:
~15% of the proceeds of the sale as a permanent EOS stake (for storage and report processing)
~75% of the proceeds for sequencing materials and AGE payroll.
In essence, we become a vendor to the community. If AGE does a poor job of serving the community - they are free to vote us out and source a new sequencing service.
The code we use will be open sourced before we add genetic information to it.
I understand I'm not getting the word out very well - I and my team are focusing on this 100% now.
Thank you for your comment,
Greg